Predictive Role of Neutrophil Gelatinase-Associated Lipocalin in Early Diagnosis of Platin-Induced Renal Injury |
Seker, Mehmet Metin
(Medical Oncology Department, Faculty of Medicine, Cumhuriyet University)
Deveci, Koksal (Biochemistry Department, Faculty of Medicine, Cumhuriyet University) Seker, Ayse (Public Health Directorate) Sancakdar, Enver (Biochemistry Department, Faculty of Medicine, Cumhuriyet University) Yilmaz, Ali (Internal Medicine Department, Faculty of Medicine, Cumhuriyet University) Turesin, A. Kerim (Internal Medicine Department, Faculty of Medicine, Cumhuriyet University) Kacan, Turgut (Medical Oncology Department, Faculty of Medicine, Cumhuriyet University) Babacan, Nalan A. (Medical Oncology Department, Faculty of Medicine, Cumhuriyet University) |
1 | Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S (2006). Neutrophil-gelatinaseassociated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol, 26, 287-92. DOI |
2 | Bennett M, Dent CL, Ma Q, et al (2008). Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol, 3, 665-73. DOI |
3 | Berry DA, Cronin KA, Plevritis SK, et al (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 353, 1784-92. DOI |
4 | Brawley OW (2011). Avoidable cancer deaths globally. CA Cancer J Clin, 61, 67-8. DOI |
5 | Devarajan P (2008). Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury. Nephrol Dial Transplant, 23, 3737-43. DOI |
6 | Gaspari F, Cravedi P, Mandala M, et al (2010). Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract, 115, 154-60. DOI |
7 | Haase M, Bellomo R, Devarajan P, et al (2009). Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis, 54, 1012-24. DOI |
8 | Haase M, Haase-Fielitz A, Bellomo R, et al (2009). Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med, 37, 39-47. DOI |
9 | Haase M, Haase-Fielitz A, Bellomo R, Mertens PR (2011). Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease. Curr Opin Hematol, 18, 11-8. DOI |
10 | Haase M, Mertens PR (2010). Urinary biomarkers--silver bullets to faster drug development and nephron protection. Nephrol Dial Transplant, 25, 3167-9. DOI |
11 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
12 | Kos FT, Sendur MA, Aksoy S, et al (2013). Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapy. Asian Pac J Cancer Prev, 14, 1111-4. DOI |
13 | Launay-Vacher V, Oudard S, Janus N, et al (2007). Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer, 110, 1376-84. DOI |
14 | Lichtman SM, Wildiers H, Launay-Vacher V, et al (2007). International society of geriatric oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer, 43, 14-34. DOI |
15 | Lin HY, Lee SC, Lin SF, et al (2013). Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatininduced acute kidney injury better than albuminuria or urinary cystatin C levels. Kaohsiung J Med Sci, 29, 304-11. DOI |
16 | Ling W, Zhaohui N, Ben H, et al (2008). Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract, 108, 176-81. DOI |
17 | Mishra J, Mori K, Ma Q, et al (2004). Neutrophil gelatinaseassociated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol, 24, 307-15. DOI |
18 | Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S (2009). Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail, 31, 910-9. DOI |
19 | Mishra J, Dent C, Tarabishi R, et al (2005). Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet, 365, 1231-8. DOI |
20 | Mishra J, Ma Q, Prada A, et al (2003). Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol, 14, 2534-43. DOI |
21 | Nickolas TL, Barasch J, Devarajan P (2008). Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens, 17, 127-32. DOI |
22 | Parikh CR, Devarajan P (2008). New biomarkers of acute kidney injury. Crit Care Med, 36, 159-65. DOI |
23 | Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. DOI |
24 | Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009). Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol, 27, 2758-65. DOI |
25 | Wagener G, Jan M, Kim M, et al (2006). Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology, 105, 485-91. DOI |